↓ Skip to main content

Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis

Overview of attention for article published in Degenerative Neurological and Neuromuscular Disease, May 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)

Mentioned by

news
3 news outlets
twitter
1 X user
facebook
1 Facebook page

Readers on

mendeley
159 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
Published in
Degenerative Neurological and Neuromuscular Disease, May 2017
DOI 10.2147/dnnd.s135748
Pubmed ID
Authors

Michael Hinchcliffe, Alan Smith

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 159 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 13%
Student > Ph. D. Student 20 13%
Student > Master 19 12%
Researcher 15 9%
Student > Doctoral Student 7 4%
Other 19 12%
Unknown 58 36%
Readers by discipline Count As %
Neuroscience 26 16%
Medicine and Dentistry 20 13%
Biochemistry, Genetics and Molecular Biology 19 12%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Agricultural and Biological Sciences 7 4%
Other 20 13%
Unknown 58 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2024.
All research outputs
#1,336,267
of 26,388,722 outputs
Outputs from Degenerative Neurological and Neuromuscular Disease
#6
of 98 outputs
Outputs of similar age
#24,987
of 329,489 outputs
Outputs of similar age from Degenerative Neurological and Neuromuscular Disease
#2
of 3 outputs
Altmetric has tracked 26,388,722 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 98 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 329,489 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.